查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426951

消化不良藥物市場- 適應症（功能性、有機）、藥物類型（質子幫浦抑制劑、H-2-受體拮抗劑、制酸劑、抗生素）、藥物（品牌、學名藥）、模式（OTC、處方）、配銷通路、全球預測（ 2024-2032）

Dyspepsia Drugs Market - Indication (Functional, Organic), Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics), Medication (Branded, Generic), Mode (OTC, Prescription), Distribution Channel, Global Forecast (2024-2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

由於不同族群消化系統疾病的發生率不斷上升，預計 2024 年至 2032 年消化不良藥物市場的CAGR將達到 4.5%。現代生活方式的特徵是不穩定的飲食習慣、壓力水平增加和久坐行為，導致消化問題激增，導致對消化不良藥物的需求不斷成長。

根據 2021 年全國醫院門診醫療調查，近 840 萬人因消化系統問題前往急診室就診。人口老化更容易出現胃腸道問題，因此對先進、有效的消化不良藥物產生了持續的需求。隨著醫療保健意識的增強，患者尋求及時有效的解決方案，進一步刺激市場成長。

消化不良藥物市場依據適應症、藥物類型、用藥、模式、配銷通路和區域進行分類。

有機適應症領域預計 2024 年至 2032 年間CAGR將達到 4%。消費者擴大尋求自然和整體的方法來管理消化不適，從而推動對有機消化不良藥物的需求。這種向有機解決方案的轉變符合注重健康的消費者選擇的更廣泛趨勢。因此，製藥公司正在投資研發，以創造創新的有機消化不良藥物，提供全面的治療選擇，以滿足消費者不斷變化的偏好。

2024 年和 2032 年，學名藥領域的CAGR將超過 5.8%，因為它們是為更廣泛的患者群體提供的負擔得起的替代品。隨著幾種消化不良品牌藥物的專利到期，學名藥已變得普遍，在不影響療效的情況下提供具有成本效益的解決方案。這不僅提高了可近性，而且還加劇了競爭，促進了創新並降低了整體治療成本。隨著全球醫療保健系統努力控制成本，學名藥領域將顯著成長。

在消化系統疾病盛行率不斷上升且積極主動的醫療基礎設施的推動下，歐洲消化不良藥物市場規模預計CAGR為 3.8%。由於飲食變化、生活方式因素和老化，歐洲人口的胃腸道問題正在激增。對醫療保健創新和研究的承諾導致了先進消化不良藥物的開發。此外，嚴格的監管標準確保了這些藥物的安全性和有效性，並增強了醫療保健提供者和患者的信心。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：消化不良藥物市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 消化不良盛行率增加
      • 人口老化加劇
      • 對非處方藥 (OTC) 的偏好不斷上升
    • 產業陷阱與挑戰
      • 與消化不良藥物相關的副作用
      • 替代療法的可用性
  • 成長潛力分析
  • 監管環境
  • 定價分析
  • 流行病學
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：消化不良藥物市場估計與預測：按適應症，2018-2032

  • 主要動向：依指示
  • 功能性消化不良
  • 器質性消化不良

第 6 章：消化不良藥物市場估計與預測：按藥物類型，2018-2032

  • 主要動向：依藥物類型
  • 質子幫浦抑制劑
  • H-2-受體拮抗劑
  • 制酸劑
  • 抗生素
  • 促動力
  • 抗憂鬱藥

第 7 章：消化不良藥物市場估計與預測：按藥物分類，2018-2032

  • 主要動力向：透過藥物治療
  • 品牌化
  • 通用的

第 8 章：消化不良藥物市場估計與預測：按模式，2018-2032

  • 主要動向：按模式
  • 在櫃檯
  • 處方

第 9 章：消化不良藥物市場估計與預測：按配銷通路，2018-2032

  • 主要動向：按配銷通路
  • 零售藥局
  • 醫院藥房
  • 網路藥局

第 10 章：消化不良藥物市場估計與預測：按地區，2018 - 2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 11 章：公司簡介

  • Takeda Pharmaceutical Company Limited
  • AstraZeneca plc
  • Salix Pharmaceuticals, Inc.
  • Abbott Laboratories
  • Pfizer Inc.
  • Sanofi SA
  • Procter & Gamble
  • Haleon plc
  • ANI Pharmaceuticals, Inc.
  • Dr Reddy's Laboratories Ltd.
Product Code: 7670

Dyspepsia Drugs Market is expected to witness 4.5% CAGR from 2024 to 2032 owing to the escalating incidence of digestive disorders across demographics. The modern lifestyle, characterized by erratic eating habits, increased stress levels, and sedentary behavior, has contributed to a surge in digestive issues, leading to a growing demand for dyspepsia medications.

According to the National Hospital Ambulatory Medical Care Survey 2021, nearly 8.4 million people visited emergency departments for digestive system issues. The aging population is more susceptible to gastrointestinal problems, creating a sustained need for advanced and efficient dyspepsia drugs. As healthcare awareness increases, patients seek prompt and effective solutions, further stimulating the market growth.

The dyspepsia drugs market is classified based on indication, drug type, medication, mode, distribution channel, and region.

The organic indication segment is anticipated to record 4% CAGR between 2024 and 2032. Consumers are increasingly seeking natural and holistic approaches to manage digestive discomfort, driving the demand for organic dyspepsia medications. This shift towards organic solutions aligns with the broader trend of health-conscious consumer choices. As a result, pharmaceutical companies are investing in R&D to create innovative organic dyspepsia drugs, offering a comprehensive range of treatment options to meet the evolving preferences of consumers.

The generic medication segment will observe more than 5.8% CAGR during 2024 and 2032 as they are affordable alternatives provided to a broader patient base. With the expiration of patents for several branded dyspepsia drugs, generic versions have become prevalent, offering cost-effective solutions without compromising efficacy. This has not only improved accessibility but has also intensified the competition, fostering innovation and driving down overall treatment costs. As healthcare systems worldwide strive for cost containment, the generic medication segment will record notable growth.

Europe dyspepsia drugs market size is predicted to observe 3.8% CAGR over the forecast, driven by the increasing prevalence of digestive disorders and a proactive healthcare infrastructure. European population is experiencing a surge in gastrointestinal issues due to dietary changes, lifestyle factors, and aging. The commitment to healthcare innovation and research is resulting in the development of advanced dyspepsia drugs. Moreover, stringent regulatory standards ensure the safety and efficacy of these medications, fostering confidence among both healthcare providers and patients.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Dyspepsia drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Indication trends
    • 2.1.4 Drug type trends
    • 2.1.5 Medication trends
    • 2.1.6 Mode trends
    • 2.1.7 Distribution channel trends

Chapter 3 Dyspepsia Drugs Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of dyspepsia
      • 3.2.1.2 Growing aging population
      • 3.2.1.3 Rising preference for over-the-counter (OTC) medications
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with the dyspepsia drugs
      • 3.2.2.2 Availability of alternative therapies
  • 3.3 Growth potential analysis
    • 3.3.1 By indication
    • 3.3.2 By drug type
    • 3.3.3 By medication
    • 3.3.4 By mode
    • 3.3.5 By distribution channel
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis
  • 3.6 Epidemiology
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2023
  • 4.3 Competitive analysis of major market players, 2023
  • 4.4 Competitive positioning matrix, 2023
  • 4.5 Strategic dashboard, 2023

Chapter 5 Dyspepsia Drugs Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)

  • 5.1 Key trends, by indication
  • 5.2 Functional dyspepsia
  • 5.3 Organic dyspepsia

Chapter 6 Dyspepsia Drugs Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)

  • 6.1 Key trends, by drug type
  • 6.2 Proton pump inhibitors
  • 6.3 H-2-receptor antagonists
  • 6.4 Antacids
  • 6.5 Antibiotics
  • 6.6 Prokinetics
  • 6.7 Antidepressants

Chapter 7 Dyspepsia Drugs Market Estimates and Forecast, By Medication, 2018-2032 (USD Million)

  • 7.1 Key trends, by medication
  • 7.2 Branded
  • 7.3 Generic

Chapter 8 Dyspepsia Drugs Market Estimates and Forecast, By Mode, 2018-2032 (USD Million)

  • 8.1 Key trends, by mode
  • 8.2 Over-the-counter
  • 8.3 Prescription

Chapter 9 Dyspepsia Drugs Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 9.1 Key trends, by distribution channel
  • 9.2 Retail pharmacies
  • 9.3 Hospital pharmacies
  • 9.4 Online pharmacies

Chapter 10 Dyspepsia Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East & Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

  • 11.1 Takeda Pharmaceutical Company Limited
  • 11.2 AstraZeneca plc
  • 11.3 Salix Pharmaceuticals, Inc.
  • 11.4 Abbott Laboratories
  • 11.5 Pfizer Inc.
  • 11.6 Sanofi SA
  • 11.7 Procter & Gamble
  • 11.8 Haleon plc
  • 11.9 ANI Pharmaceuticals, Inc.
  • 11.10 Dr Reddy's Laboratories Ltd.

Data Tables

  • TABLE 1. Market Revenue, by indication (2023)
  • TABLE 2. Market Revenue, by drug type (2023)
  • TABLE 3. Market Revenue, by medication (2023)
  • TABLE 4. Market Revenue, by mode (2023)
  • TABLE 5. Market Revenue, by distribution channel (2023)
  • TABLE 6. Market share, by region (2023)
  • TABLE 7. Global dyspepsia drugs market size, by region, 2018 - 2023 (USD Million)
  • TABLE 8. Global dyspepsia drugs market size, by region, 2024 - 2032 (USD Million)
  • TABLE 9. Global dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 10. Global dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 11. Global dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 12. Global dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 13. Global dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 14. Global dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 15. Global dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 16. Global dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 17. Global dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 18. Global dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 19. Industry impact forces
  • TABLE 20. Functional dyspepsia market size, 2018 - 2023 (USD Million)
  • TABLE 21. Functional dyspepsia market size, 2024 - 2032 (USD Million)
  • TABLE 22. Organic dyspepsia market size, 2018 - 2023 (USD Million)
  • TABLE 23. Organic dyspepsia market size, 2024 - 2032 (USD Million)
  • TABLE 24. Proton pump inhibitors market size, 2018 - 2023 (USD Million)
  • TABLE 25. Proton pump inhibitors market size, 2024 - 2032 (USD Million)
  • TABLE 26. H-2-receptor antagonists market size, 2018 - 2023 (USD Million)
  • TABLE 27. H-2-receptor antagonists market size, 2024 - 2032 (USD Million)
  • TABLE 28. Antacids market size, 2018 - 2023 (USD Million)
  • TABLE 29. Antacids market size, 2024 - 2032 (USD Million)
  • TABLE 30. Antibiotics market size, 2018 - 2023 (USD Million)
  • TABLE 31. Antibiotics market size, 2024 - 2032 (USD Million)
  • TABLE 32. Prokinetics market size, 2018 - 2023 (USD Million)
  • TABLE 33. Prokinetics market size, 2024 - 2032 (USD Million)
  • TABLE 34. Antidepressants market size, 2018 - 2023 (USD Million)
  • TABLE 35. Antidepressants market size, 2024 - 2032 (USD Million)
  • TABLE 36. Branded market size, 2018 - 2023 (USD Million)
  • TABLE 37. Branded market size, 2024 - 2032 (USD Million)
  • TABLE 38. Generic market size, 2018 - 2023 (USD Million)
  • TABLE 39. Generic market size, 2024 - 2032 (USD Million)
  • TABLE 40. Over-the-counter market size, 2018 - 2023 (USD Million)
  • TABLE 41. Over-the-counter market size, 2024 - 2032 (USD Million)
  • TABLE 42. Prescription market size, 2018 - 2023 (USD Million)
  • TABLE 43. Prescription market size, 2024 - 2032 (USD Million)
  • TABLE 44. Retail pharmacies market size, 2018 - 2023 (USD Million)
  • TABLE 45. Retail pharmacies market size, 2024 - 2032 (USD Million)
  • TABLE 46. Hospital pharmacies market size, 2018 - 2023 (USD Million)
  • TABLE 47. Hospital pharmacies market size, 2024 - 2032 (USD Million)
  • TABLE 48. Online pharmacies market size, 2018 - 2023 (USD Million)
  • TABLE 49. Online pharmacies market size, 2024 - 2032 (USD Million)
  • TABLE 50. North America dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 51. North America dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 52. North America dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 53. North America dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 54. North America dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 55. North America dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 56. North America dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 57. North America dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 58. North America dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 59. North America dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 60. North America dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 61. North America dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 62. U.S. dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 63. U.S. dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 64. U.S. dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 65. U.S. dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 66. U.S. dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 67. U.S. dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 68. U.S. dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 69. U.S. dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 70. U.S. dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 71. U.S. dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 72. Canada dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 73. Canada dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 74. Canada dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 75. Canada dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 76. Canada dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 77. Canada dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 78. Canada dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 79. Canada dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 80. Canada dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 81. Canada dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 82. Europe dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 83. Europe dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 84. Europe dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 85. Europe dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 86. Europe dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 87. Europe dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 88. Europe dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 89. Europe dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 90. Europe dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 91. Europe dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 92. Europe dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 93. Europe dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 94. Germany dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 95. Germany dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 96. Germany dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 97. Germany dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 98. Germany dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 99. Germany dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 100. Germany dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 101. Germany dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 102. Germany dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 103. Germany dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 104. UK dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 105. UK dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 106. UK dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 107. UK dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 108. UK dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 109. UK dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 110. UK dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 111. UK dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 112. UK dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 113. UK dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 114. France dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 115. France dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 116. France dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 117. France dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 118. France dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 119. France dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 120. France dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 121. France dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 122. France dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 123. France dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 124. Spain dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 125. Spain dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 126. Spain dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 127. Spain dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 128. Spain dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 129. Spain dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 130. Spain dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 131. Spain dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 132. Spain dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 133. Spain dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 134. Italy dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 135. Italy dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 136. Italy dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 137. Italy dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 138. Italy dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 139. Italy dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 140. Italy dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 141. Italy dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 142. Italy dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 143. Italy dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 144. Rest of Europe dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 145. Rest of Europe dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 146. Rest of Europe dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 147. Rest of Europe dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 148. Rest of Europe dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 149. Rest of Europe dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 150. Rest of Europe dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 151. Rest of Europe dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 152. Rest of Europe dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 153. Rest of Europe dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 154. Asia Pacific dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 155. Asia Pacific dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 156. Asia Pacific dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 157. Asia Pacific dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 158. Asia Pacific dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 159. Asia Pacific dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 160. Asia Pacific dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 161. Asia Pacific dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 162. Asia Pacific dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 163. Asia Pacific dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 164. Asia Pacific dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 165. Asia Pacific dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 166. China dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 167. China dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 168. China dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 169. China dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 170. China dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 171. China dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 172. China dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 173. China dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 174. China dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 175. China dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 176. Japan dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 177. Japan dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 178. Japan dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 179. Japan dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 180. Japan dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 181. Japan dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 182. Japan dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 183. Japan dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 184. Japan dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 185. Japan dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 186. India dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 187. India dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 188. India dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 189. India dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 190. India dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 191. India dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 192. India dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 193. India dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 194. India dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 195. India dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 196. Australia dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 197. Australia dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 198. Australia dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 199. Australia dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 200. Australia dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 201. Australia dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 202. Australia dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 203. Australia dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 204. Australia dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 205. Australia dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 206. Rest of Asia Pacific dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 207. Rest of Asia Pacific dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 208. Rest of Asia Pacific dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 209. Rest of Asia Pacific dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 210. Rest of Asia Pacific dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 211. Rest of Asia Pacific dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 212. Rest of Asia Pacific dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 213. Rest of Asia Pacific dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 214. Rest of Asia Pacific dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 215. Rest of Asia Pacific dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 216. Latin America dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 217. Latin America dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 218. Latin America dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 219. Latin America dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 220. Latin America dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 221. Latin America dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 222. Latin America dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 223. Latin America dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 224. Latin America dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 225. Latin America dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 226. Latin America dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 227. Latin America dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 228. Brazil dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 229. Brazil dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 230. Brazil dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 231. Brazil dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 232. Brazil dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 233. Brazil dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 234. Brazil dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 235. Brazil dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 236. Brazil dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 237. Brazil dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 238. Mexico dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 239. Mexico dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 240. Mexico dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 241. Mexico dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 242. Mexico dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 243. Mexico dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 244. Mexico dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 245. Mexico dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 246. Mexico dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 247. Mexico dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 248. Rest of Latin America dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 249. Rest of Latin America dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 250. Rest of Latin America dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 251. Rest of Latin America dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 252. Rest of Latin America dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 253. Rest of Latin America dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 254. Rest of Latin America dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 255. Rest of Latin America dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 256. Rest of Latin America dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 257. Rest of Latin America dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 258. Middle East & Africa dyspepsia drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 259. Middle East & Africa dyspepsia drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 260. Middle East & Africa dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 261. Middle East & Africa dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 262. Middle East & Africa dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 263. Middle East & Africa dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 264. Middle East & Africa dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 265. Middle East & Africa dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 266. Middle East & Africa dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 267. Middle East & Africa dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 268. Middle East & Africa dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 269. Middle East & Africa dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 270. South Africa dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 271. South Africa dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 272. South Africa dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 273. South Africa dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 274. South Africa dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 275. South Africa dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 276. South Africa dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 277. South Africa dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 278. South Africa dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 279. South Africa dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 280. Saudi Arabia dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 281. Saudi Arabia dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 282. Saudi Arabia dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 283. Saudi Arabia dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 284. Saudi Arabia dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 285. Saudi Arabia dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 286. Saudi Arabia dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 287. Saudi Arabia dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 288. Saudi Arabia dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 289. Saudi Arabia dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 290. Rest of Middle East & Africa dyspepsia drugs market size, by indication, 2018 - 2023 (USD Million)
  • TABLE 291. Rest of Middle East & Africa dyspepsia drugs market size, by indication, 2024 - 2032 (USD Million)
  • TABLE 292. Rest of Middle East & Africa dyspepsia drugs market size, by drug type, 2018 - 2023 (USD Million)
  • TABLE 293. Rest of Middle East & Africa dyspepsia drugs market size, by drug type, 2024 - 2032 (USD Million)
  • TABLE 294. Rest of Middle East & Africa dyspepsia drugs market size, by medication, 2018 - 2023 (USD Million)
  • TABLE 295. Rest of Middle East & Africa dyspepsia drugs market size, by medication, 2024 - 2032 (USD Million)
  • TABLE 296. Rest of Middle East & Africa dyspepsia drugs market size, by mode, 2018 - 2023 (USD Million)
  • TABLE 297. Rest of Middle East & Africa dyspepsia drugs market size, by mode, 2024 - 2032 (USD Million)
  • TABLE 298. Rest of Middle East & Africa dyspepsia drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 299. Rest of Middle East & Africa dyspepsia drugs market size, by distribution channel, 2024 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Top-down approach
  • FIG. 3 Market estimation and forecast methodology
  • FIG. 4 Market forecasting methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Dyspepsia drugs industry 360 degree synopsis, 2018 - 2032
  • FIG. 7 Growth potential analysis, by indication
  • FIG. 8 Growth potential analysis, by drug type
  • FIG. 9 Growth potential analysis, by medication
  • FIG. 10 Growth potential analysis, by mode
  • FIG. 11 Growth potential analysis, by distribution channel
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Company matrix analysis, 2023
  • FIG. 15 Competitive analysis of major market players, 2023
  • FIG. 16 Competitive positioning matrix, 2023
  • FIG. 17 Strategic dashboard, 2023